Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP116702.RAqgLRL0sHKC8uOW_pR5uS67bhkEKV2oyQnleUjRLOiOA130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP116702.RAqgLRL0sHKC8uOW_pR5uS67bhkEKV2oyQnleUjRLOiOA130_assertion type Assertion NP116702.RAqgLRL0sHKC8uOW_pR5uS67bhkEKV2oyQnleUjRLOiOA130_head.
- NP116702.RAqgLRL0sHKC8uOW_pR5uS67bhkEKV2oyQnleUjRLOiOA130_assertion description "[A cohort of 1,575 BRCA1 and 856 BRCA2 mutation carriers was used to evaluate haplotypes at ATM, BARD1, BRIP1, CTIP, MRE11, NBS1, RAD50, RAD51, and TOPBP1 in ovarian cancer risk.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP116702.RAqgLRL0sHKC8uOW_pR5uS67bhkEKV2oyQnleUjRLOiOA130_provenance.
- NP116702.RAqgLRL0sHKC8uOW_pR5uS67bhkEKV2oyQnleUjRLOiOA130_assertion evidence source_evidence_literature NP116702.RAqgLRL0sHKC8uOW_pR5uS67bhkEKV2oyQnleUjRLOiOA130_provenance.
- NP116702.RAqgLRL0sHKC8uOW_pR5uS67bhkEKV2oyQnleUjRLOiOA130_assertion SIO_000772 19584272 NP116702.RAqgLRL0sHKC8uOW_pR5uS67bhkEKV2oyQnleUjRLOiOA130_provenance.
- NP116702.RAqgLRL0sHKC8uOW_pR5uS67bhkEKV2oyQnleUjRLOiOA130_assertion wasDerivedFrom gad-20150221 NP116702.RAqgLRL0sHKC8uOW_pR5uS67bhkEKV2oyQnleUjRLOiOA130_provenance.
- NP116702.RAqgLRL0sHKC8uOW_pR5uS67bhkEKV2oyQnleUjRLOiOA130_assertion wasGeneratedBy ECO_0000203 NP116702.RAqgLRL0sHKC8uOW_pR5uS67bhkEKV2oyQnleUjRLOiOA130_provenance.